Infinity Laboratories continues to grow scope and reach of services with the acquisition of MicroMed Laboratories
CASTLE ROCK, CO – June 24, 2020 – Infinity Laboratories (infinitylaboratories.com) is proud to announce the acquisition of MicroMed Laboratories of Petaluma, CA. Founded in 1999, MicroMed Laboratories is a publicly held Environmental Monitoring and Testing Services Company and a division of Sonoma Pharmaceuticals, Inc. [NASDAQ: SNOA]. MicroMed offers Cleanroom Services and Validations, Environmental Monitoring and a wide spectrum of microbiology tests.
Dan Henderson, President and Chief Executive Officer of Infinity Laboratories stated;
“MicroMed Labs has been the Bay Area’s go-to laboratory within the MedTech and Pharmaceutical industry for more than 20 years. Their success has been accomplished by a fantastic team of Scientists and Leaders who understand how to serve customers in a dynamic and highly regulated environment. We are excited to continue their legacy by enhancing their success through best-in-class technology and systems.
We are also eager to leverage MicroMed Labs’ Clean Room Certification program and in the upcoming months plan to launch a national program that will take these critical services from West Coast to East Coast.”
Infinity Laboratories is a rapidly expanding network of state-of the-art testing facilities that are FDA Registered, ISO 17025 Accredited and DEA licensed. MicroMed Laboratories is in compliance with the ISO 13485 quality system, is ISO 9001:2015 Accredited and complies with CGMP and Quality System Regulations.
The goal of Infinity Laboratories is to go Beyond Testing and become a partner in the success of their customers by providing quality testing and timely, accurate results – the addition of MicroMed increases the capability and the capacity of the Infinity Laboratories family.
For more information contact:
Gary L. Doucette: 720-369-2077
About Infinity Laboratories
Infinity Laboratories was founded in 1991 on the bedrock principles of excellence, integrity, and quality. Today, the Company is a national chemical and microbiological testing laboratory servicing the pharmaceutical, biotechnology and medical device industries.
For more information about Infinity Laboratories, please visit: infinitylaboratories.com
For more information about MicroMed, please visit: micromedlabs.com
EY Announces Dan Henderson of Infinity Laboratories as an Entrepreneur Of The Year® 2020 Mountain Desert Region Award Finalist
Castle Rock, CO - September 9, 2020 - Ernst & Young LLP (EY US) announced that CEO/President Dan Henderson of Infinity Laboratories was named an Entrepreneur Of The Year® 2020 Mountain Desert Region Award finalist. Now in its 34th year, the Entrepreneur Of The Year...
CASTLE ROCK, CO - July 17, 2020 - Infinity Laboratories (infinitylaboratories.com) is excited to announce the acquisition of DYNALABS of St. Louis, MO. Founded in 2003, DYNALABS is a privately held Analytical Testing Laboratory that offers Lab Services, On Site...
Expanded testing capabilities with developed method for Hydroxychloroquine (HCQ). Effective April 16, 2020 - Infinity Laboratories has added a validated method for Hydroxychloroquine and is now receiving final product samples for potency testing. Hydroxychloroquine...